|Application ||WB, IHC, IHC-P, IF|
|Reactivity||Human, Mouse, Rat, Bovine|
|Dilution||IF (1:1000-1:2000), IHC (1:1000-1:2000), IHC-P (1:500), WB (1:5000-1:10000) ,|
|Other Names||Visinin-like protein 1, VILIP, VLP-1, Hippocalcin-like protein 3, HLP3, VSNL1, VISL1|
|Target/Specificity||The antibody is known to react with VLP-1 from human, cow, mouse and rat. Since VLP-1 is highly conserved in primary sequence, it is likely that the antibody is effective on other species also.|
|Reconstitution & Storage||+4°C or -20°C, Avoid repeated freezing and thawing.|
|Precautions||VILIP / VSNL1 Antibody is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||Regulates (in vitro) the inhibition of rhodopsin phosphorylation in a calcium-dependent manner.|
|Tissue Location||Brain and retina. Neuron-specific in the central and peripheral nervous system. Increased in the cerebrospinal fluid of Alzheimer disease patients (at protein level).|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Regulates (in vitro) the inhibition of rhodopsin phosphorylation in a calcium-dependent manner.
Polymeropoulos M.H.,et al.Genomics 29:273-275(1995).
Bellingham J.,et al.Submitted (DEC-1997) to the EMBL/GenBank/DDBJ databases.
Kobayashi M.,et al.DNA Seq. 9:171-176(1998).
Mural R.J.,et al.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
Lee J.M.,et al.Clin. Chem. 54:1617-1623(2008).
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.